In early childhood, the neurons inside children’s developing brains form connections between various regions of brain. Researchers at San Diego State University found that in children and adolescents with autism spectrum disorder, the connections between the cerebral cortex and the cerebellum appear to be overdeveloped in sensorimotor regions of the brain. This overdevelopment appears to muscle in on brain neural networks that in typically developing children is more densely occupied by connections that serve higher cognitive functioning. The study is published in the journal Biological Psychiatry.
The current study represents the first ever systematic look at neural networks and connections between the entire cerebral cortex and the cerebellum using fMRI brain imaging, and its findings provide another piece in the puzzle that could one day lead researchers to develop a reliable brain-based test for identifying autism.
In previous studies researchers reported findings that certain regions of the cerebellum, a brain region involved in motor control, but also in cognitive, social, and emotional functions, were often smaller in people with autism than in typically developing people. That sparked a brief flurry of research activity exploring the cerebellum’s potential role in the disorder. Unfortunately, the direction never truly panned out for researchers hoping for a big breakthrough in understanding, state the team. Eventually, interest in the cerebellum waned due to a lack of consistency in the findings.
Now, hoping that advances in brain imaging technology would reveal new insights the team looked back to the cerebellum for the current study. The researchers directed 56 children and adolescents, half with autism and half without the disorder, to fixate on a focal point while thinking about nothing in particular, using fMRI brain imaging technology to scan the children’s brains as they produced spontaneous brain activity. Capturing this spontaneous activity is crucial to honing in on what are essentially baseline neuronal patterns.
The imaging results in the current study revealed that the participants with autism had far stronger neuronal connectivity between sensorimotor regions of the cerebellum and cerebral cortex than did their counterparts without autism. Conversely, the participants with autism had less connectivity between regions involved in higher-order cognitive functions such as decision-making, attention and language.
The team explain that the sensorimotor connections between the cerebral cortex and cerebellum mature during the first few years of life, when the brains of children with autism grow larger in volume than typically developing children. Connections that serve higher cognitive functions develop later, after this period of overgrowth.
The data findings suggest that the early developing sensorimotor connections are highly represented in the cerebellum at the expense of higher cognitive functions in children with autism. By the time the higher cognitive functions begin to come online, many of the connections are already specialized. If a particular part of the brain or neural network is already functionally active in one domain, there may be no reason for the brain to switch it over to another domain later in life.
The findings could help scientists and clinicians better understand exactly how abnormalities during brain development lead to various types of autism spectrum disorder. The team add that they hope this work will not only contribute to a brain-based diagnosis of autism, but also be a step towards identifying its various subtypes and underlying genetic factors.
The team surmise that the medical community still don’t understand what in the brain makes a kid autistic. However, the medical community are doing the groundwork by finding brain variables that might be biomarkers for autism and its subtypes.
Source: San Diego State University
Michelle is a health industry veteran who taught and worked in the field before training as a science journalist.
Featured by numerous prestigious brands and publishers, she specializes in clinical trial innovation--expertise she gained while working in multiple positions within the private sector, the NHS, and Oxford University.